Your browser doesn't support javascript.
loading
Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
Collij, Lyduine E; Heeman, Fiona; Kuijer, Joost P A; Ossenkoppele, Rik; Benedictus, Marije R; Möller, Christiane; Verfaillie, Sander C J; Sanz-Arigita, Ernesto J; van Berckel, Bart N M; van der Flier, Wiesje M; Scheltens, Philip; Barkhof, Frederik; Wink, Alle Meije.
Afiliação
  • Collij LE; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Heeman F; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Kuijer JP; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Ossenkoppele R; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Benedictus MR; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Möller C; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Verfaillie SC; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Sanz-Arigita EJ; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • van Berckel BN; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • van der Flier WM; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Scheltens P; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Barkhof F; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
  • Wink AM; From the Department of Radiology and Nuclear Medicine (L.E.C., F.H., E.J.S.A., B.N.M.v.B., F.B., A.M.W.), Department of Physics and Medical Technology (J.P.A.K.), and Alzheimer Centre and Department of Neurology (R.O., M.R.B., C.M., S.C.J.V., W.M.v.d.F., P.S.), VU University Medical Centre, Boelelaa
Radiology ; 281(3): 865-875, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27383395
Purpose To investigate whether multivariate pattern recognition analysis of arterial spin labeling (ASL) perfusion maps can be used for classification and single-subject prediction of patients with Alzheimer disease (AD) and mild cognitive impairment (MCI) and subjects with subjective cognitive decline (SCD) after using the W score method to remove confounding effects of sex and age. Materials and Methods Pseudocontinuous 3.0-T ASL images were acquired in 100 patients with probable AD; 60 patients with MCI, of whom 12 remained stable, 12 were converted to a diagnosis of AD, and 36 had no follow-up; 100 subjects with SCD; and 26 healthy control subjects. The AD, MCI, and SCD groups were divided into a sex- and age-matched training set (n = 130) and an independent prediction set (n = 130). Standardized perfusion scores adjusted for age and sex (W scores) were computed per voxel for each participant. Training of a support vector machine classifier was performed with diagnostic status and perfusion maps. Discrimination maps were extracted and used for single-subject classification in the prediction set. Prediction performance was assessed with receiver operating characteristic (ROC) analysis to generate an area under the ROC curve (AUC) and sensitivity and specificity distribution. Results Single-subject diagnosis in the prediction set by using the discrimination maps yielded excellent performance for AD versus SCD (AUC, 0.96; P < .01), good performance for AD versus MCI (AUC, 0.89; P < .01), and poor performance for MCI versus SCD (AUC, 0.63; P = .06). Application of the AD versus SCD discrimination map for prediction of MCI subgroups resulted in good performance for patients with MCI diagnosis converted to AD versus subjects with SCD (AUC, 0.84; P < .01) and fair performance for patients with MCI diagnosis converted to AD versus those with stable MCI (AUC, 0.71; P > .05). Conclusion With automated methods, age- and sex-adjusted ASL perfusion maps can be used to classify and predict diagnosis of AD, conversion of MCI to AD, stable MCI, and SCD with good to excellent accuracy and AUC values. © RSNA, 2016.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Marcadores de Spin / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Marcadores de Spin / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2016 Tipo de documento: Article